These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 8731234

  • 1. Interleukin-6 and soluble interleukin-2 receptor in juvenile chronic arthritis: correlations with clinical and laboratory parameters.
    Spadaro A, Riccieri V, Sili Scavalli A, Sensi F, Fiore D, Taccari E, Zoppini A.
    Rev Rhum Engl Ed; 1996 Mar; 63(3):171-7. PubMed ID: 8731234
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Soluble adhesion molecules in juvenile rheumatoid arthritis.
    Bloom BJ, Miller LC, Tucker LB, Schaller JG, Blier PR.
    J Rheumatol; 1999 Sep; 26(9):2044-8. PubMed ID: 10493690
    [Abstract] [Full Text] [Related]

  • 5. Soluble interleukin-2 receptor in juvenile rheumatoid arthritis.
    Silverman ED, Laxer RM, Nelson DL, Rubin LA.
    J Rheumatol; 1991 Sep; 18(9):1398-402. PubMed ID: 1757944
    [Abstract] [Full Text] [Related]

  • 6. Serum levels of hyaluronic acid indicate the severity of joint symptoms in patients with systemic and polyarticular juvenile rheumatoid arthritis.
    Takei S, Imanaka H, Maeno N, Shigemori M, Masuda K, Hokonohara M, Miyata K.
    J Rheumatol; 1996 Nov; 23(11):1956-62. PubMed ID: 8923375
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
    Peake NJ, Khawaja K, Myers A, Nowell MA, Jones SA, Rowan AD, Cawston TE, Foster HE.
    Rheumatology (Oxford); 2006 Dec; 45(12):1485-9. PubMed ID: 16690760
    [Abstract] [Full Text] [Related]

  • 8. Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis.
    De Benedetti F, Pignatti P, Gerloni V, Massa M, Sartirana P, Caporali R, Montecucco CM, Corti A, Fantini F, Martini A.
    J Rheumatol; 1997 Jul; 24(7):1403-9. PubMed ID: 9228145
    [Abstract] [Full Text] [Related]

  • 9. Sleep and its relationship to pain, dysfunction, and disease activity in juvenile rheumatoid arthritis.
    Bloom BJ, Owens JA, McGuinn M, Nobile C, Schaeffer L, Alario AJ.
    J Rheumatol; 2002 Jan; 29(1):169-73. PubMed ID: 11824956
    [Abstract] [Full Text] [Related]

  • 10. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
    Zeft A, Hollister R, LaFleur B, Sampath P, Soep J, McNally B, Kunkel G, Schlesinger M, Bohnsack J.
    J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
    [Abstract] [Full Text] [Related]

  • 11. Circulating levels of soluble E-selectin, P-selectin and intercellular adhesion molecule-1 in patients with juvenile idiopathic arthritis.
    De Benedetti F, Vivarelli M, Pignatti P, Oliveri M, Massa M, Pistorio A, Martini A.
    J Rheumatol; 2000 Sep; 27(9):2246-50. PubMed ID: 10990242
    [Abstract] [Full Text] [Related]

  • 12. Prognostic factors in juvenile chronic arthritis.
    Dequeker J, Mardjuadi A.
    J Rheumatol; 1982 Sep; 9(6):909-15. PubMed ID: 6984466
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of disease activity by laboratory tests in juvenile rheumatoid arthritis.
    Martínez-Cordero E, Orozco Barocio G, Martínez Miranda E.
    J Investig Allergol Clin Immunol; 1995 Sep; 5(4):216-20. PubMed ID: 8705012
    [Abstract] [Full Text] [Related]

  • 14. Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction.
    Jouvenne P, Vannier E, Dinarello CA, Miossec P.
    Arthritis Rheum; 1998 Jun; 41(6):1083-9. PubMed ID: 9627018
    [Abstract] [Full Text] [Related]

  • 15. Serum soluble intercellular adhesion molecule 1 and interleukin 8 levels in familial Mediterranean fever.
    Direskeneli H, Ozdogan H, Korkmaz C, Akoglu T, Yazici H.
    J Rheumatol; 1999 Sep; 26(9):1983-6. PubMed ID: 10493680
    [Abstract] [Full Text] [Related]

  • 16. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.
    Usón J, Balsa A, Pascual-Salcedo D, Cabezas JA, Gonzalez-Tarrio JM, Martín-Mola E, Fontan G.
    J Rheumatol; 1997 Nov; 24(11):2069-75. PubMed ID: 9375862
    [Abstract] [Full Text] [Related]

  • 17. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
    Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, Brunner HI, Griffin T, Graham TB, Sherry DD, Passo MH, Ramanan AV, Filipovich A, Grom AA.
    Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
    [Abstract] [Full Text] [Related]

  • 18. Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis.
    Saxena N, Aggarwal A, Misra R.
    J Rheumatol; 2005 Jul; 32(7):1349-53. PubMed ID: 15996076
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis.
    Maeno N, Takei S, Imanaka H, Takasaki I, Kitajima I, Maruyama I, Matsuo K, Miyata K.
    J Rheumatol; 1999 Oct; 26(10):2244-8. PubMed ID: 10529148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.